This study examines whether silencing specific β-nerve growth factor small interfering RNA (β-NGF siRNA) can affect the growth of ectopic endometriotic implants, generalized hyperalgesia, and nerve fiber density in endometriosis.
Methods:
Four specific β-NGF siRNAs were detected by Western blot analysis, and the most efficient specific siRNA was transferred into rats with surgically induced endometriosis through gene transfer. The length × width × height of each ectopic transplant that survived from 2 groups were measured at pre-and postbombardment after 2 weeks. The transplants were collected 2 weeks after bombardment. Warm-water tail flick test was performed before the rats were sacrificed. The specimens were sectioned and stained immunohistochemically with antibodies against the types of nerve fibers to compare the presence of different nerve fibers in the treatment and control groups. The serums and supernatants of the peritoneal washings in the treatment and control groups were collected for enzyme-linked immunosorbent assay (ELISA) analysis. The extra rats were successfully induced with endometriosis and through gene transfer as described above. The spherical volumes of the transplants and tail flick latency post-bombardment after 4, 6, 8, and 10 weeks were measured.
Results:
The spherical volumes in the treatment group were much smaller than those in the control group, and tail flick latency significantly increased in the treatment group postbombardment after 2 weeks. The ELISA analysis showed that the concentrations of β-NGF in the serums and supernatants of the peritoneal fluid decreased in the treatment group unlike in the control group. Less sympathetic and sensory innervation was observed in the treatment group postbombardment after 2 weeks. The outcomes of the spherical volumes of the transplants and tail flick latency postbombardment after 4, 6, 8, and 10 weeks showed that the sizes of the transplants did not return to their previous size and that the treatment had some effects on generalized hyperalgesia.
Conclusion:
Specific siRNA-mediated silencing of the β-NGF gene expression after gene transfer suppressed the growth of ectopic endometriotic implants resulted in a significant improvement in generalized hyperalgesia as well as reduced sympathetic and sensory nerve fiber density in the treatment group.
VercelliniPDe GiorgiOPisacretaAPesoleAPVicentiniSCrosignaniPG. Surgical management of endometriosis. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14(3):501–523.
2.
CandianiGBFedeleLVercelliniPBianchiSDi NolaG. Repetitive conservative surgery for recurrence of endometriosis. Obstet Gynecol. 1991;77(3):421–424.
3.
OosterlynckDJCornillieFJWaerMVandeputteMKoninckxPR. Women with endometriosis show a defect in natural killer activity resulting in a decreased cytotoxicity to autologous endometrium. Fertil Steril. 1991;56(1):45–51.
4.
KoninckxPRKennedySHBarlowDH. Pathogenesis of endometriosis: the role of peritoneal fluid. Gynecol Obstet Invest. 1999;47(suppl 1):23–33.
5.
WoolfCJAllchorneASafieh-GarabedianBPooleS. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol. 1997;121(3):417–424.
6.
WatkinsLRMaierSFGoehlerLE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain. 1995;63(3):289–302.
7.
AnafVSimonPEl NakadiIRelationship between endometriotic foci and nerves in rectovaginal endometriotic nodules. Hum Reprod. 2000;15(8):1744–1750.
8.
BerkleyKJRapkinAJPapkaRE. The pains of endometriosis. Science. 2005;308(5728):1587–1589.
9.
TokushigeNMarkhamRRussellPFraserIS. High density of small nerve fibres in the functional layer of the endometrium in women with endometriosis. Hum Reprod. 2006;21(3):782–787.
10.
FarinasI. Neurotrophin actions during the development of the peripheral nervous system. Microsc Res Tech. 1999;45(4-5):233–242.
11.
ShuXQMendellLM. Neurotrophins and hyperalgesia. Proc Natl Acad Sci U S A. 1999;96(14):7693–7696.
12.
WoolfCJ. Phenotypic modification of primary sensory neurons: the role of nerve growth factor in the production of persistent pain. Philos Trans R Soc Lond B Biol Sci. 1996;351(1338):441–448.
13.
GeeAPBoyleMDMungerKLLawmanMJYoungM. Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci U S A. 1983;80(23):7215–7218.
14.
DyckPJPeroutkaSRaskCIntradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology. 1997;48(2):501–505.
15.
DelafoyLRaymondFDohertyAMEschalierADiopL. Role of nerve growth factor in the trinitrobenzene sulfonic acid-induced colonic hypersensitivity. Pain. 2003;105(3):489–497.
16.
SevcikMAGhilardiJRPetersCMAnti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain. 2005;115(1-2):128–141.
BiFLiuNFanD. Small interfering RNA: a new tool for gene therapy. Curr Gene Ther. 2003;3(5):411–417.
22.
TamburroSCanisMAlbuissonEDechelottePDarchaCMageG. Expression of transforming growth factor beta1 in nerve fibers is related to dysmenorrhea and laparoscopic appearance of endometriotic implants. Fertil Steril. 2003;80(5):1131–1136.
23.
TokushigeNMarkhamRRussellPFraserIS. Different types of small nerve fibers in eutopic endometrium and myometrium in women with endometriosis. Fertil Steril. 2007;88(4):795–803.
24.
TokushigeNMarkhamRRussellPFraserIS. Nerve fibres in peritoneal endometriosis. Hum Reprod. 2006;21(11):3001–3007.
25.
BerkleyKJDmitrievaNCurtisKSPapkaRE. Innervation of ectopic endometrium in a rat model of endometriosis. Proc Natl Acad Sci U S A. 2004;101(30):11094–11098.
26.
WangGTokushigeNMarkhamRFraserIS. Rich innervation of deep infiltrating endometriosis. Hum Reprod. 2009;24(4):827–834.
27.
DolleLEl Yazidi-BelkouraIAdriaenssensENurcombeVHondermarckH. Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene. 2003;22(36):5592–5601.
28.
AdriaenssensEVanheckeESaulePNerve growth factor is a potential therapeutic target in breast cancer. Cancer Res. 2008;68(2):346–351.
29.
ZulfikarogluEKilicSIslimyeMAydinMZergerogluSBatiogluS. Efficacy of anti-tumor necrosis factor therapy on endometriosis in an experimental rat model. Arch Gynecol Obstet. 2011;283(4):799–804.
30.
LashbrookJMOssipovMHHunterJCRaffaRBTallaridaRJPorrecaF. Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1—and COX2-inhibitors in nerve-injured rats. Pain. 1999;82(1):65–72.
31.
JonesBGDickinsonPAGumbletonMKellawayIW. The inhibition of phagocytosis of respirable microspheres by alveolar and peritoneal macrophages. Int J Pharm. 2002;236(1-2):65–79.
32.
BerkleyKJCasonAJacobsHBradshawHWoodE. Vaginal hyperalgesia in a rat model of endometriosis. Neurosci Lett. 2001;306(3):185–188.
33.
LuYNieJLiuXZhengYGuoSW. Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. Hum Reprod. 2010;25(4):1014–1025.
34.
HeWLiuXZhangYGuoSW. Generalized hyperalgesia in women with endometriosis and its resolution following a successful surgery. Reprod Sci. 2010;17(12):1099–1111.
35.
CasonAMSamuelsenCLBerkleyKJ. Estrous changes in vaginal nociception in a rat model of endometriosis. Horm Behav. 2003;44(2):123–131.
36.
HowardFM. Endometriosis and mechanisms of pelvic pain. J Minim Invasive Gynecol. 2009;16(5):540–550.
37.
McAllisterSLDmitrievaNBerkleyKJ. Sprouted innervation into uterine transplants contributes to the development of hyperalgesia in a rat model of endometriosis. PLoS One. 2012;7(2):e31758.
38.
ApfelSC. Neurotrophic factors and pain. Clin J Pain. 2000;16(suppl 2):S7–S11.
39.
KesslerJABlackIB. Nerve growth factor stimulates the development of substance P in sensory ganglia. Proc Natl Acad Sci U S A. 1980;77(1):649–652.
40.
DavisBMLewinGRMendellLMJonesMEAlbersKM. Altered expression of nerve growth factor in the skin of transgenic mice leads to changes in response to mechanical stimuli. Neuroscience. 1993;56(4):789–792.
41.
RueffAMendellLM. Nerve growth factor NT-5 induce increased thermal sensitivity of cutaneous nociceptors in vitro. J Neurophysiol. 1996;76(5):3593–3596.
42.
HillRGOliverKR.Neuropeptide and kinin antagonists. Handb Exp Pharmacol. 2007(177):181–216.
43.
ZhangGDmitrievaNLiuYMcGintyKABerkleyKJ. Endometriosis as a neurovascular condition: estrous variations in innervation, vascularization, and growth factor content of ectopic endometrial cysts in the rat. Am J Physiol Regul Integr Comp Physiol. 2008;294(1):R162–R171.
FreemontAJWatkinsALe MaitreCNerve growth factor expression and innervation of the painful intervertebral disc. J Pathol. 2002;197(3):286–292.
46.
MichaelGJPriestleyJV. Differential expression of the mRNA for the vanilloid receptor subtype 1 in cells of the adult rat dorsal root and nodose ganglia and its downregulation by axotomy. J Neurosci. 1999;19(5):1844–1854.
47.
KaplanDRMillerFD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol. 2000;10(3):381–391.
48.
AverillSDelcroixJDMichaelGJTomlinsonDRFernyhoughPPriestleyJV. Nerve growth factor modulates the activation status and fast axonal transport of ERK 1/2 in adult nociceptive neurones. Mol Cell Neurosci. 2001;18(2):183–196.
49.
JiRRBabaHBrennerGJWoolfCJ. Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity. Nat Neurosci. 1999;2(12):1114–1119.
50.
WoolfCJCostiganM. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci U S A. 1999;96(14):7723–7730.
51.
WrightDESniderWD. Neurotrophin receptor mRNA expression defines distinct populations of neurons in rat dorsal root ganglia. J Comp Neurol. 1995;351(3):329–338.
52.
Barcena de ArellanoMLArnoldJVercellinoFChianteraVSchneiderAMechsnerS. Overexpression of nerve growth factor in peritoneal fluid from women with endometriosis may promote neurite outgrowth in endometriotic lesions. Fertil Steril. 2011;95(3):1123–1126.
53.
SheltonDLZellerJHoWHPonsJRosenthalA. Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain. 2005;116(1-2):8–16.
54.
SledzCAHolkoMde VeerMJSilvermanRHWilliamsBR. Activation of the interferon system by short-interfering RNAs. Nat Cell Biol. 2003;5(9):834–839.
55.
HornungVGuenthner-BillerMBourquinCSequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med. 2005;11(3):263–270.
56.
MorrisseyDVLockridgeJAShawLPotent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol. 2005;23(8):1002–1007.
57.
MarquesJTWilliamsBR. Activation of the mammalian immune system by siRNAs. Nat Biotechnol. 2005;23(11):1399–1405.
